APPLICATION
ANDA213195
TYPE
ANDA
ORIGINAL APPROVAL
2023-07-06
LATEST ACTION
2023-07-06
ROUTE
INTRAMUSCULAR
DOSAGE FORM
FOR SUSPENSION, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
NALTREXONEDiscontinued
NALTREXONE 380MG/VIAL · FOR SUSPENSION, EXTENDED RELEASE · INTRAMUSCULAR
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.